|
111
|
336
|
4iacA |
X-ray structure of camp dependent protein kinase a in complex with high mg2+ concentration, amp-pcp and pseudo-substrate peptide sp20 |
|
71
|
266
|
4j8nA |
Aurora a kinase apo |
|
91
|
297
|
4j97A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic gain-of-function k659e mutation identified in endometrial cancer. |
|
86
|
324
|
4i23A |
Crystal structure of the wild-type egfr kinase domain in complex with dacomitinib (soaked) |
|
95
|
354
|
4izyA |
Crystal structure of jnk1 in complex with jip1 peptide and 4-{4-[4-(4-methanesulfonyl-piperidin-1-yl)-indol-1-yl]-pyrimidin-2-ylamino}-cyclohexan |
|
73
|
273
|
4i41A |
Crystal structure of human ser/thr kinase pim1 in complex with mitoxantrone |
|
93
|
290
|
4jdkA |
Crystal structure of serine/threonine-protein kinase pak 4 f461v mutant in complex with paktide s peptide substrate |
|
95
|
354
|
4hysA |
Crystal structure of jnk1 in complex with jip1 peptide and 4-(4-indazol-1-yl-pyrimidin-2-ylamino)-cyclohexan |
|
67
|
264
|
4jxfA |
Crystal structure of plk4 kinase with an inhibitor: 400631 ((1r,2s)-2-{3-[(e)-2-{4-[(dimethylamino)methyl]phenyl}ethenyl]-2h-indazol-6-yl}-5'-methoxyspiro[cyclopropane-1,3'-indol]-2'(1'h)-one) |
|
101
|
348
|
4i5hA |
Crystal structure of a double mutant rat erk2 complexed with a type ii quinazoline inhibitor |
|
91
|
288
|
4i6qA |
Jak3 kinase domain in complex with 2-phenoxy-5h-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((s)-1-cyclopropyl-ethyl)-amide |
|
90
|
323
|
4imyA |
The aff4 scaffold binds human p-tefb adjacent to hiv tat |
|
88
|
299
|
4j99A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the gain-of-function k659t mutation. |
|
86
|
324
|
4jrvA |
Crystal structure of egfr kinase domain in complex with compound 4c |
|
83
|
229
|
4i6lA |
Crystal structure of otub1 in complex with ubiquitin variant |
|
100
|
320
|
4jnwA |
Bacterially expressed titin kinase |
|
92
|
315
|
4i24A |
Structure of t790m egfr kinase domain co-crystallized with dacomitinib |
|
107
|
343
|
4idtA |
Crystal structure of nik with 11-bromo-5,6,7,8-tetrahydropyrimido[4',5':3,4]cyclohepta[1,2-b]indol-2-amine (t28) |
|
100
|
330
|
4ianA |
Crystal structure of apo human prpf4b kinase domain |
|
195
|
659
|
4iwpA |
Crystal structure and mechanism of activation of tbk1 |
|
95
|
290
|
4jdhA |
Crystal structure of serine/threonine-protein kinase pak 4 in complex with paktide t peptide substrate |
|
70
|
275
|
4jvgA |
B-raf kinase in complex with birb796 |
|
90
|
302
|
4ivbA |
Jak1 kinase (jh1 domain) in complex with the inhibitor trans-4-{2-[(1r)-1-hydroxyethyl]imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6h)-yl}cyclohexanecarbonitrile |
|
78
|
274
|
4jx3A |
Crystal structure of pim1 kinase |
|
212
|
659
|
4im2A |
Structure of tank-binding kinase 1 |
|
70
|
279
|
4js8A |
Crystal structure of ttk kinase domain with an inhibitor: 401348 |
|
91
|
298
|
4j95A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic k659n mutation responsible for an unclassified craniosynostosis syndrome in space group c2. |
|
86
|
324
|
4jq8A |
Crystal structure of egfr kinase domain in complex with compound 4b |
|
88
|
290
|
4ji9A |
Jak2 kinase (jh1 domain) in complex with tg101209 |
|
90
|
315
|
4i22A |
Structure of the monomeric (v948r)gefitinib/erlotinib resistant double mutant (l858r+t790m) egfr kinase domain co-crystallized with gefitinib |
|
107
|
336
|
4iayA |
Room temperature x-ray structure of camp dependent protein kinase a in complex with high sr2+ concentration, adp and phosphorylated peptide psp20 |
|
116
|
348
|
4izaA |
Structure of dually phosphorylated erk2 bound to the pea-15 death effector domain |
|
89
|
300
|
4jiaA |
Jak2 kinase (jh1 domain) in complex with compound 9 |
|
108
|
338
|
4ib1A |
Structure of camp dependent protein kinase a in complex with high k+ concentration, adp and phosphorylated peptide psp20 |
|
105
|
346
|
4ix4A |
Crystal structure of a stt7 homolog from micromonas algae in complex with adp |
|
91
|
332
|
4hzsA |
Crystal structure of ack1 kinase domain with c-terminal sh3 domain |
|
83
|
289
|
4i93A |
Structure of the bsk8 kinase domain (semet labeled) |
|
85
|
265
|
4jbpA |
Novel aurora kinase inhibitors reveal mechanisms of hurp in nucleation of centrosomal and kinetochore microtubules |
|
72
|
273
|
4id7A |
Ack1 kinase in complex with the inhibitor cis-3-[8-amino-1-(4-phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol |
|
75
|
287
|
4ithA |
Crystal structure of rip1 kinase in complex with necrostatin-1 analog |
|
91
|
296
|
4i3zA |
Structure of pcdk2/cyclina bound to adp and 2 magnesium ions |
|
94
|
336
|
4ijpA |
Crystal structure of human prpf4b kinase domain in complex with 4-{5-[(2-chloro-pyridin-4-ylmethyl)-carbamoyl]-thiophen-2-yl}-benzo[b]thiophene-2-carboxylic acid amine |
|
76
|
266
|
4j8mA |
Aurora a in complex with cd532 |
|
99
|
301
|
4ibmA |
Crystal structure of insulin receptor kinase domain in complex with an inhibitor irfin-1 |
|
85
|
293
|
4j53A |
Crystal structure of plk1 in complex with tak-960 |
|
80
|
300
|
4jg8A |
Structure of rsk2 t493m ctd mutant bound to 2-cyano-n-(1-hydroxy-2-methylpropan-2-yl)-3-(3-(3,4,5-trimethoxyphenyl)-1h-indazol-5-yl)acrylamide |
|
82
|
287
|
4i20A |
Crystal structure of monomeric (v948r) primary oncogenic mutant l858r egfr kinase domain |
|
96
|
348
|
4j1rA |
Crystal structure of gsk3b in complex with inhibitor 15r |
|
97
|
354
|
4hyuA |
Crystal structure of jnk1 in complex with jip1 peptide and 4-{4-[4-(3-methanesulfonyl-propoxy)-indazol-1-yl]-pyrimidin-2-ylamino}-cyclohexan |
|
74
|
273
|
4iaaA |
Crystal structure of ser/thr kinase pim1 in complex with thioridazine |
